These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 3114485)

  • 41. [Relation of antiphospholipid antibodies to thrombotic phenomena and clinical activity of systemic lupus erythematosus].
    Font J; Cervera R; Casals FJ; Bové A; Guerrero A; López-Soto A; Ingelmo M; Urbano-Márquez A
    Med Clin (Barc); 1988 Mar; 90(12):490-3. PubMed ID: 3134583
    [No Abstract]   [Full Text] [Related]  

  • 42. A common anti-DNA idiotype and other autoantibodies in sera of offspring of mothers with systemic lupus erythematosus.
    el-Roeiy A; Gleicher N; Isenberg D; Kennedy RC; Shoenfeld Y
    Clin Exp Immunol; 1987 Jun; 68(3):528-34. PubMed ID: 3115649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
    Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
    Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical significance of antiphospholipid autoantibodies in lupus erythematosus].
    Pozsonyi T; Lakos G; Jakab L; Baraczka K; Jánoskuti L; Kleiber M; Sipka S; Pajor A; Szegedi G
    Orv Hetil; 1998 Oct; 139(40):2363-8. PubMed ID: 9796352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significance of anticardiolipin antibodies in connective tissue diseases].
    Scagliusi P; Tortorelli E; L'Abbate MC; Pipitone V
    Minerva Med; 1989 Oct; 80(10):1059-68. PubMed ID: 2682375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
    Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
    Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of antiphospholipid antibodies in lupus nephritis.
    Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.
    Asherson RA; Khamashta MA; Gil A; Vazquez JJ; Chan O; Baguley E; Hughes GR
    Am J Med; 1989 Apr; 86(4):391-9. PubMed ID: 2494884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies.
    Delezé M; Oria CV; Alarcón-Segovia D
    J Rheumatol; 1988 Apr; 15(4):611-5. PubMed ID: 3274208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antiphospholipid antibodies: new data in the pathogenesis of collagenosis].
    Grob JJ; Bonerandi JJ
    Ann Dermatol Venereol; 1986; 113(9):811-8. PubMed ID: 3548543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus.
    Wong KL; Liu HW; Ho K; Chan K; Wong R
    J Rheumatol; 1991 Aug; 18(8):1187-92. PubMed ID: 1941822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Measurement of anticardiolipin antibodies and its significance in systemic lupus erythematosus].
    Bao CD; Chen SL; Jiang SJ
    Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):74-7, 125. PubMed ID: 2500315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The antiphospholipid antibody syndrome: a new clinical and therapeutic viewpoint in systemic lupus erythematosus].
    Bravo-Vargas G; Lavalle-Montalvo C
    Gac Med Mex; 1988; 124(1-2):39-42. PubMed ID: 3145236
    [No Abstract]   [Full Text] [Related]  

  • 58. Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study.
    de Bandt M; Benali K; Guillevin L; Hachulla E; Job C; Fautrel B; Fournié G; Bonnet C; Fournié B; Le Goff P; Jorgensen C; Meyer O
    J Rheumatol; 1999 Jan; 26(1):91-6. PubMed ID: 9918247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Khamashta MA; Amengual O; Hughes GR
    J Rheumatol; 1998 Jun; 25(6):1104-8. PubMed ID: 9632071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.